Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
Open Access
- 1 December 2000
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 6 (6), 585-594
- https://doi.org/10.3201/eid0606.000606
Abstract
Volume 22, Number 8—August 2016 - Emerging Infectious Disease journal - CDCKeywords
This publication has 50 references indexed in Scilit:
- When Being Hyper Keeps You FitScience, 2000
- Praziquantel – Its Use, Cost and Possible Development of ResistancePublished by Elsevier ,1999
- Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoniParasitology, 1998
- (Ca2+-Mg2+)ATPase in Schistosoma mansoni: evidence for heterogeneity and resistance to praziquantelMemórias do Instituto Oswaldo Cruz, 1998
- Emerging and Reemerging Helminthiases and the Public Health of ChinaEmerging Infectious Diseases, 1997
- Schistosomiasis Japonica in the Philippines: The Long-Term Impact of Population-Based Chemotherapy on Infection, Transmission, and MorbidityThe Journal of Infectious Diseases, 1996
- Adaptive evolution of highly mutable loci in pathogenic bacteriaCurrent Biology, 1994
- Age-targeted chemotherapy for control of urinary schistosomiais in endemic populationsMemórias do Instituto Oswaldo Cruz, 1992
- Schistosoma haematobium infection in Mauritania: two years of follow-up after a targeted chemotherapy — a life-table approach of the risk of reinfectionParasitology, 1990
- Praziquantel: a new schistosomicide against Schistosoma haematobium.BMJ, 1979